［1］ WANG YG,LIU HT,ZHANG Y,et al.cDNA cloning and expression of an apoptosis-related gene,human TFAR15 gene［J］.Science in China(Series C:Life Sciences),1999,03:323-329.
[2] BERGAMETTI F,DENIER C,LABAUGE P,et al.Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations［J］.The American Journal of Human Genetics,2005,76(1):42-51.
[3] GUCLU B,OZTURK AK,PRICOLA KL,et al.Mutations in apoptosis-related gene,PDCD10,cause cerebral cavernous malformation 3［J］.Neurosurgery,2005,57(5):1008-1013.
[4] 孙荣华，黄家强，韩文玲，等.小鼠凋亡相关新基因TFAR15的克隆和序列分析［J］.细胞与分子免疫学杂志,2000,02:97-100.
SUN RH,HUANG JQ,HAN WL,et al.Cloning and sequence analysis of TFAR15 gene associated with apoptosis in mice［J］.Journal of Cellular and Molecular Immunology,2000,02:97-100.
[5] KEAN MJ,CECCARELLI DF,GOUDREAULT M,et al.Structure-function analysis of core STRIPAK proteins:a signaling complex implicated in Golgi polarization［J］.The Journal of Biological Chemistry,2011,286(28):25065-25075.
[6] LI XF,ZHANG R,ZHANG HF,et al.Crystal structure of CCM3,a cerebral cavernous malformation protein critical for vascular integrity［J］.The Journal of Biological Chemistry,2010,285(31):24099-24107.
[7] FIDALGO M,FRAILE M,PIRES A,et al.CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation［J］.Journal of Cell Science,2010,123(Pt 8):1274-1284.
[8] HILDER TL,MALONE MH,BENCHARIT S,et al.Proteomic identification of the cerebral cavernous malformation signaling complex［J］.Journal of Proteome Research,2007,6(11):4343-4355.
[9] VOSS K,STAHL S,SCHLEIDER E,et al.CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations［J］.Neurogenetics,2007,8(4):249-256.
[10] LI XF,JI WD,ZHANG R,et al.Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3)［J］.The Journal of Biological Chemistry,2011,286(29):26138-26147.
[11] GOUDREAULT M,D'AMBROSIO LM,KEAN MJ,et al.A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein［J］.Molecular & Cellular Proteomics,2009,8(1):157-171.
[12] 马曦,赵红珊,马大龙.人程序性细胞死亡因子10(PDCD10):不仅与细胞凋亡相关［J］.生物化学与生物物理进展,2007,34（08):781-790.
MA X,ZHAO HS,MA DL.Human programmed cell death factor 10 (PDCD10):not only associated with apoptosis［J］.Progress in Biochemistry and Biophysics,2007,34（08):781-790.
[13] ZHU Y,WU Q,XU JF,et al.Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations［J］.Neurosurgical Focus,2010,29(3):E1.
[14] SCHLEIDER E,STAHL S,WUSTEHUBE J,et al.Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3［J］.Neurogenetics,2011,12(1):83-86.
[15] LOUVI A,CHEN LL,TWO AM,et al.Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology［J］.Proceedings of the National Academy of Sciences of the United States of America,2011,108(9):3737-3742.
[16] LAUENBORG B,KOPP K,KREJSGAARD T,et al.Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis［J］.Acta Pathologica,Microbiologica,et Immunologica Scandinavica,2010,118(10):719-728.
[17] CHEN LL,TANRIOVER G,YANO H,et al.Apoptotic functions of PDCD10/CCM3,the gene mutated in cerebral cavernous malformation 3［J］.Stroke,2009,40(4):1474-1481.
[18] LIN CY,MENG SX,ZHU TN,et al.PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival［J］.The Journal of Biological Chemistry,2010,285(53):41675-41685.
[19] YOU C,SANDALCIOGLU IE,DAMMANN P,et al.Loss of CCM3 impairs DLL4-Notch signalling:implication in endothelial angiogenesis and in inherited cerebral cavernous malformations［J］.Journal of Cellular and Molecular Medicine,2013,17(3):407-418.
[20] LOUVI A,NISHIMURA S,GUNEL M.CCM3,a gene associated with cerebral cavernous malformations,is required for neuronal migration［J］.Journal of Cell Science,2014,127(6):e1.
[21] YORUK B,GILLERS BS,CHI NC,et al.CCM3 functions in a manner distinct from CCM1 and CCM2 in a zebrafish model of CCM vascular disease［J］.Developmental Biology,2011,362(2):121-131.
[22] HE Y,ZHANG HF,YU LY,et al.Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development［J］.Sci Signal,2010,3(116):ra26.
[23] CHAN AC,DRAKOS SG,RUIZ OE,et al.Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice［J］.The Journal of Clinical Investigation,2011,121(5):1871-1881.
[24] MA X,ZHAO HS,SHAN JX,et al.PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway［J］.Molecular Biology of the Cell,2007,18(6):1965-1978.
[25] LAMBERTZ N,EI HN,KREITSCHMANN-ANDERMAHR I,et al.Downregulation of programmed cell death 10 is associated with tumor cell proliferation,hyperangiogenesis and peritumoral edema in human glioblastoma［J］.BMC Cancer,2015,15(1):759.
[26] WAN XY,SABAN DV,KIM SN,et al.PDCD10-deficiency promotes malignant behaviors and tumor growth via triggering EphB4 kinase activity in glioblastoma［J］.Frontiers in Oncology,2020,10:1377.
[27] WU SS,WANG JW,LIU JD,et al.Programmed cell death 10 increased blood-brain barrier permeability through HMGB1/TLR4 mediated downregulation of endothelial ZO-1 in glioblastoma［J］.Cellular Signalling,2023,107:110683.
[28] XU XF,GE SF,JIA RB,et al.Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6［J］.Oncology Reports,2015,33(6):2789-2796.
[29] ZHU Y,ZHAO K,PRINZ A,et al.Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth［J］.Neuro-Oncology,2016,18(4):538-548.
[30] LIU JD,WANG JW,TIAN WD,et al.PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling［J］.Aging,2022,14(15):6066.
[31] ZHANG HY,MA X,PENG SH,et al.Differential expression of MST4,STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer［J］.International Journal of Clinical and Experimental Pathology,2014,7(11):8105-8111.
[32] FU XL,ZHANG W,SU YS,et al.MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer［J］.The Prostate,2016,76(6):543-551.
[33] FENG ZM,QIU J,CHEN XW,et al.Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium［J］.BMC Cancer,2015,15(1):645.
[34] YANG D,WANG JJ,LI JS,et al.MiR-103 functions as a tumor suppressor by directly targeting programmed cell death 10 in NSCLC［J］.Oncology Research,2017,26(4):519-528.
[35] WU K,MU XY,JIANG JT,et al.miRNA-26a-5p and miR-26b-5p inhibit the proliferation of bladder cancer cells by regulating PDCD10［J］.Oncol Rep,2018,40(6):3523-3532.
[36] URFALI-MAMATOGLU C,KAZAN HH,GUNDUZ U.Dual function of programmed cell death 10 (PDCD10) in drug resistance［J］.Biomedicine & Pharmacotherapy,2018,101:129-136.
[37] XU K,FEI WC,HUO ZQ,et al.PDCD10 promotes proliferation,migration,and invasion of osteosarcoma by inhibiting apoptosis and activating EMT pathway［J］.Cancer Medicine,2022,12(2):1673-1684.
[38] TAN P,YE YQ,HE L,et al.TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10［J］.PLoS Biology,2018,16(11):e3000051.
[39] SUN B,ZHONG FJ,XU C,et al.Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation［J］.Cell Death & Disease,2021,12(9):849.
[40] DONG CH,FAN B,REN ZT,et al.CircSMARCA5 facilitates the progression of prostate cancer through miR-432/PDCD10 axis［J］.Cancer Biotherapy & Radiopharmaceuticals,2020,36(1):70-83.
[41] FAN LL,LEI H,ZHANG S,et al.Erratum:Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10:Erratum［J］.Theranostics,2024,14(3):1098.
[42] ZHOU QW,BREITKOPF-HEINLEIN K,GAITANTZI H,et al.PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer［J］.Clinical Science (London,England:1979),2024,138(18):1111-1129.
[43] ZHANG M,DONG L,SHI ZB,et al.Structural mechanism of CCM3 heterodimerization with GCKIII kinases［J］.Structure (London,England:1993),2013,21(4):680-688.
[44] WANG S,ENGLUND E,KJELLMAN P,et al.Retraction note:CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling［J］.Nature Cell Biology,2024,26:1817.
[45] ZHANG Y,HU XQ,MIAO XF,et al.MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of programmed cell death 10［J］.Journal of Cellular and Molecular Medicine,2016,20(2):360-369.
[46] XU Y,ZHU M.Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer［J］.Clinical & Translational Oncology,2020,22(7):1105-1116.
[47] NICKEL AC,WAN XY,SABAN DV,et al.Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma［J］.Journal of Neuro-Oncology,2019,141(1):31-41.
[48] ZHU Y,KIM SN,CHEN ZR,et al.PDCD10 is a key player in TMZ-resistance and tumor cell regrowth:insights into its underlying mechanism in glioblastoma cells［J］.Cells,2024,13(17):1442.
[49] ZHANG Q,WANG JW,YAO XL,et al.Programmed cell death 10 mediated CXCL2-CXCR2 signaling in regulating tumor-associated microglia/macrophages recruitment in glioblastoma［J］.Frontiers in Immunology,2021,12:637053.
[50] LAWAL B,KUO YC,TANG SL,et al.Transcriptomic-based identification of the immuno-oncogenic signature of cholangiocarcinoma for HLC-018 multi-target therapy exploration［J］.Cells,2021,10(11):2873.
[51] VIALLARD C,LARRIVEE B.Tumor angiogenesis and vascular normalization:alternative therapeutic targets［J］.Angiogenesis,2017,20(4):409-426.
[52] JIANG WJ,SHI XL,SUN LZ,et al.Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner［J］.International Journal of Biological Sciences,2023,19(14):4571-4587.